Anika Therapeutics (ANIK) Retained Earnings (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Retained Earnings of $59.0 million for Q2 2026, down 6.02% year-over-year from $62.8 million in Q2 2025, and up 5.94% quarter-over-quarter from $55.7 million in Q1 2026.
Anika Therapeutics (ANIK) Retained Earnings (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Retained Earnings for 17 consecutive years, with $59.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Retained Earnings fell 6.02% year-over-year to $59.0 million; the TTM figure through Jun 2026 stood at $59.0 million (down 6.02% YoY), while the FY2025 annual figure was $60.8 million, down 15.18% from the prior year.
- Retained Earnings rose to $59.0 million in Q2 2026 per ANIK's latest filing, from $55.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $222.6 million in Q1 2022 and bottomed at $55.7 million in Q1 2026.
- Historically, Retained Earnings has averaged $131.3 million across 5 years, with a median of $123.5 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings retreated 0.73% — and 2024, when it sank 51.04%.
- Anika Therapeutics' Retained Earnings stood at $210.7 million in 2022, then slumped by 39.23% to $128.1 million in 2023, then slumped by 44.03% to $71.7 million in 2024, then dropped by 15.18% to $60.8 million in 2025, then fell by 2.87% to $59.0 million in 2026.
- Business Quant data shows ANIK's Retained Earnings at $59.0 million in Q2 2026, $55.7 million in Q1 2026, and $60.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Anika Therapeutics | 284.33 Mn | 245.92 Mn | 21.24 Mn | 59.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.04 Mn |
| Mar 31, 2026 | 55.73 Mn |
| Dec 31, 2025 | 60.79 Mn |
| Sep 30, 2025 | 60.50 Mn |
| Jun 30, 2025 | 62.82 Mn |
| Mar 31, 2025 | 66.79 Mn |
| Dec 31, 2024 | 71.67 Mn |
| Sep 30, 2024 | 93.53 Mn |
| Jun 30, 2024 | 123.45 Mn |
| Mar 31, 2024 | 123.54 Mn |
| Dec 31, 2023 | 128.05 Mn |
| Sep 30, 2023 | 191.05 Mn |
| Jun 30, 2023 | 197.63 Mn |
| Mar 31, 2023 | 200.37 Mn |
| Dec 31, 2022 | 210.72 Mn |
| Sep 30, 2022 | 215.63 Mn |
| Jun 30, 2022 | 219.80 Mn |
| Mar 31, 2022 | 222.65 Mn |
| Dec 31, 2021 | 225.58 Mn |
| Sep 30, 2021 | 231.37 Mn |